Skip to content

The quality of life of women with Arthrosis using Arnica gel.

The quality of life of women with Osteoarthritis using Arnica gel (Lychnophora pinaster Mart)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-66dr73f
Enrollment
Unknown
Registered
2021-11-08
Start date
2020-03-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis

Interventions

Constituted through the application of the proposed therapy, which was performed in four weeks with a frequency of three sessions per week on alternate days. In each interversion, patients from both g
In the second exercise, the patient sat with the knee flexed at 90° and performed complete knee extension using one-kilogram shin guards. alternated. In each interversion, patients from both group 1 (
second exercise, the patient was seated with the knee flexed at 90° and performed full knee extension using one-kilogram shin pads. The researcher was given the product to be applied as a means of cou
B01.650.940.800.575.912.250.100.075 HP4.

Sponsors

Universidade Federal do Piauí
Lead Sponsor
Universidade Federal do Piauí
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: age 40 years or older; female, due to the higher prevalence of the disease; and clinical diagnosis of knee osteoarthritis according to the American College of Rheumatology (ACR) classification.

Exclusion criteria

Exclusion criteria: those who had: contraindications to the use of therapeutic ultrasound such as, area with hypoesthesia, area with vascular insufficiency, affections located in the tissue, diabetes mellitus, open wounds; hypersensitivity and allergy to Arnica or Diclofenac and its components; rheumatologic conditions such as rheumatoid arthritis; severe knee OA and lower limb thrombosis; who performed injections in the knee joint in the last 6 (six) months; balance disorders, neuropathy or sensory disturbances and skin lesions around the knee; who had undergone previous surgery on the knee joint or suffered a fractured knee joint.

Design outcomes

Primary

MeasureTime frame
Significant decrease in pain and stiffness scores and descriptive decrease in physical function score of patients with Knee Osteoarthritis determined through the WOMAC questionnaire applied before the first intervention and after the twelfth intervention, using the mann Whitney's teo test u for samples independents and the paired t-test and the wilcoxon test for dependent samples, considering a higher significance level of 5%. Decrease in pain in patients with osteoarthritis of the knee determined through the analogue pain scale (VAS) applied before and after each intervention, using the paired t test, considering a significance level greater than 5%.

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactSheyla Paiva
sheylacamylie16@gmail.com+55(86)988269246

Outcome results

None listed

Source: REBEC (via WHO ICTRP)